Showing results (31-40 of 205) with videos related to

Sort By:
Pageof 21
Journal of Visualized Experiments : Jove|July 17, 2018
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial PneumoniaTravis B Nielsen, Jun Yan, Brian Luna, et al.
American Journal of Respiratory and Critical Care Medicine|January 16, 2015
Novel approaches are needed to develop tomorrow's antibacterial therapiesBrad Spellberg, John Bartlett, Rich Wunderink, et al.
JAMA Network Open|June 23, 2025
Health Economic Analysis of an All-Virtual, At-Home Acute Care ModelBrad Spellberg, Christopher Lynch, Hal F Yee, et al.
Population Health Management|August 23, 2013
Impact of hospital variables on case mix index as a marker of disease severityCarmen M Mendez, Darrell W Harrington, Peter Christenson, et al.
Antimicrobial Agents and Chemotherapy|December 5, 2022
Antimicrobial Susceptibility Testing Performed in RPMI 1640 Reveals Azithromycin Efficacy against Carbapenem-Resistant Acinetobacter baumannii and Predicts In Vivo Outcomes in Galleria mellonellaSarah Miller, Kristine Goy, Rosemary She, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2005
Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic miceBrad Spellberg, Yue Fu, John E Edwards, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzaeAshraf S Ibrahim, Valentina Avanessian, Brad Spellberg, et al.
Medical Mycology|September 18, 2008
Economic burden of mucormycosis in the United States: can a vaccine be cost-effective?Ashraf S Ibrahim, John E Edwards, Richard Bryant, et al.
The Journal of Antimicrobial Chemotherapy|August 25, 2006
Deferiprone iron chelation as a novel therapy for experimental mucormycosisAshraf S Ibrahim, John E Edwards, Yue Fu, et al.
Clinical Investigation|September 20, 2011
Design of clinical trials of antibacterial agents for community-acquired bacterial pneumoniaBrad Spellberg, Roger J Lewis, Helen W Boucher, et al.
Pageof 21